STOCK TITAN

Amicus Therapeutics to Present at the SVB Securities Global Biopharma Conference

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences
Rhea-AI Summary

PHILADELPHIA, Feb. 08, 2023 - Amicus Therapeutics (Nasdaq: FOLD) will participate in a fireside chat at the SVB Securities Global Biopharma Conference on February 15, 2023, at 10:40 a.m. E.T. The event will be held virtually.

Investors can access the live audio webcast through the company’s investors section on their website. Amicus Therapeutics focuses on developing high-quality medicines for rare diseases, emphasizing patient care and innovative solutions. The company is committed to advancing its pipeline, aiming for first- or best-in-class treatments for patients.

Positive
  • None.
Negative
  • None.

PHILADELPHIA, Feb. 08, 2023 (GLOBE NEWSWIRE) -- Amicus Therapeutics (Nasdaq: FOLD) today announced that management will participate in a fireside chat at the SVB Securities Global Biopharma Conference, being held virtually, on Wednesday, February 15, 2023 at 10:40 a.m. E.T.

A live audio webcast of the presentation can also be accessed via the investors section of the Amicus Therapeutics corporate website at https://ir.amicusrx.com/events-and-presentations.

About Amicus Therapeutics
Amicus Therapeutics (Nasdaq: FOLD) is a global, patient-dedicated biotechnology company focused on discovering, developing and delivering novel high-quality medicines for people living with rare diseases. With extraordinary patient focus, Amicus Therapeutics is committed to advancing and expanding a pipeline of cutting-edge, first- or best-in-class medicines for rare diseases. For more information please visit the company’s website at www.amicusrx.com, and follow on Twitter and LinkedIn.

CONTACT:

Investors:
Amicus Therapeutics
Andrew Faughnan
Vice President, Investor Relations
afaughnan@amicusrx.com
(609) 662-3809

Media:
Amicus Therapeutics
Diana Moore
Head of Global Corporate Communications
dmoore@amicusrx.com
(609) 662-5079

FOLD–G


FAQ

When is Amicus Therapeutics participating in the SVB Securities Global Biopharma Conference?

Amicus Therapeutics will participate in the conference on February 15, 2023, at 10:40 a.m. E.T.

How can I access the Amicus Therapeutics presentation at the conference?

You can access the live audio webcast of the presentation through the investors section of the Amicus Therapeutics corporate website.

What is Amicus Therapeutics focused on?

Amicus Therapeutics focuses on discovering and developing novel medicines for rare diseases.

What is the stock symbol for Amicus Therapeutics?

The stock symbol for Amicus Therapeutics is FOLD.

Where can I find more information about Amicus Therapeutics?

More information can be found on the Amicus Therapeutics website at www.amicusrx.com.

Amicus Therapeutics, Inc

NASDAQ:FOLD

FOLD Rankings

FOLD Latest News

FOLD Stock Data

2.89B
267.94M
0.74%
105.23%
7.03%
Biotechnology
Pharmaceutical Preparations
Link
United States of America
PRINCETON